SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes. Hayes AG, Raven LM, Viardot A, Kotlyar E, et al. Diabetes Care 2023 Nov 14:dc231903. doi: 10.2337/dc23-1903.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hayes AG, Raven LM, Viardot A, Kotlyar E, et al. SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes. Diabetes Care 2023 Nov 14:dc231903. doi: 10.2337/dc23-1903.
PMID: 37963390